Cadence Neuroscience raises $15M Series A led by Jazz to develop Mayo Clinic–based implantable epilepsy device

Cadence Neuroscience raised $15 million in a Series A led by Jazz Venture Partners, plus support from Mayo Clinic and Epilepsy Foundation grants, to develop an implantable epilepsy therapy based on Mayo Clinic research. The Redmond startup hopes to leverage existing clinical data to accelerate development of a device aimed at patients whose seizures are not controlled by drugs.

No comments yet.